We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDER: BETTER MOLECULAR ENTITY APPLICATIONS NEEDED
CDER: BETTER MOLECULAR ENTITY APPLICATIONS NEEDED
June 18, 2004
To help expedite the drug approval process, the FDA is stepping up its efforts to get pharmaceutical companies to submit more complete applications for new molecular entities (NMEs).